Effects of chronic fluoxetine in animal models of anxiety and depression

被引:517
|
作者
Dulawa, SC
Hollick, KA
Gundersen, B
Hen, R
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
[2] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA
[3] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
关键词
BALB/c; forced swim test; novelty-induced hypophagia; open field; antidepressants;
D O I
10.1038/sj.npp.1300433
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders, Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (similar to4 days) and chronic (similar to24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect, Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
引用
下载
收藏
页码:1321 / 1330
页数:10
相关论文
共 50 条
  • [21] THE EFFECTS OF 5-HT1A RECEPTOR AGONISTS IN ANIMAL-MODELS OF ANXIETY AND DEPRESSION
    KOSTOWSKI, W
    DYR, W
    KRZASCIK, P
    PSYCHOPHARMACOLOGY, 1990, 101 : S31 - S31
  • [22] Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
    Crupi, Rosalia
    Paterniti, Irene
    Ahmad, Akbar
    Campolo, Michela
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (07) : 989 - 1001
  • [23] Effects of Milnacipran in Animal Models of Anxiety and Memory
    Vânia K. M. Moojen
    Márcio Rodrigo Martins
    Adalisa Reinke
    Gustavo Feier
    Fabiano R. Agostinho
    Édson M. Cechin
    João Quevedo
    Neurochemical Research, 2006, 31 : 571 - 577
  • [24] ANTALARMIN EFFECTS IN BEHAVIOURAL MODELS OF ANXIETY AND DEPRESSION
    Zazpe, A.
    Artaiz, I.
    Ledo, F.
    Orjales, A.
    Lucero, M. L.
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 181 - 181
  • [25] Effects of acute and chronic fluoxetine treatment on CRH-induced anxiety
    To, CT
    Anheuer, ZE
    Bagdy, G
    NEUROREPORT, 1999, 10 (03) : 553 - 555
  • [26] Deficits in neuropeptide Y in a genetic animal model of depression are normalized by chronic fluoxetine treatment
    Caberlotto, L
    Hurd, Y
    Fuxe, K
    Mathe, AA
    Overstreet, DH
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 42S - 42S
  • [27] EFFECTS OF TIANEPTINE IN ANIMAL-MODELS OF DEPRESSION
    CHAOULOFF, F
    PRESSE MEDICALE, 1991, 20 (37): : 1817 - 1822
  • [28] Behavioural effects of neurotrophins in animal models of depression
    Shirayama, Y
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S5 - S6
  • [29] Evaluation of two genetic animal models in behavioral tests of anxiety and depression
    Hinojosa, FR
    Spricigo, L
    Izídio, GS
    Brüske, GR
    Lopes, DM
    Ramos, A
    BEHAVIOURAL BRAIN RESEARCH, 2006, 168 (01) : 127 - 136
  • [30] SSRIS IN ANIMAL-MODELS OF DEPRESSION, ANXIETY AND AGGRESSION - ARE THEY ALL ALIKE
    SANCHEZ, C
    PSYCHOPHARMACOLOGY, 1995, 118 (02) : B6 - B6